Pharmaceutical News

RSS

C-SOPS, Thermo Fisher Scientific to accelerate research on continuous manufacturing techniques for drug discovery

The Engineering Research Center for Structured Organic Particulate Systems, based at the Rutgers School of Engineering, and Thermo Fisher Scientific have collaborated to accelerate the university's ongoing research on continuous manufacturing techniques for pharmaceutical discovery.c

11 Nov 2016

Arthritis drug increases effectiveness of antidepressants in bipolar patients

Giving severely depressed patients the arthritis drug celecoxib (Celebrex) dramatically boosted the effectiveness of their antidepressant medication, a Loyola study has found.

10 Nov 2016

International consortium awarded $36.9 million grant to accelerate introduction of new typhoid vaccines

Typhoid fever, a bacterial infection that causes high fever and other disabling symptoms, remains a serious global problem in the developing world: it kills almost a quarter of a million people annually, and infects about 21 million.

10 Nov 2016

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

As the global spread of the Zika virus continues, efforts are underway to halt the disease's transmission.

10 Nov 2016

Researchers lay foundation for improved TB treatment by targeting new enzyme

Researchers at Johns Hopkins report they have laid the foundation to develop novel antibiotics that work against incurable, antibiotic-resistant bacteria like tuberculosis by targeting an enzyme essential to the production and integrity of bacterial cell walls.

10 Nov 2016

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Allergan plc, a leading global pharmaceutical company, today announced the availability of TAYTULLA (norethindrone acetate and ethinyl estradiol capsules and ferrous fumarate capsules), 1mg/20mcg, the first and only oral contraceptive in a softgel capsule for the prevention of pregnancy

10 Nov 2016

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

The administration of VRC01, a potent and broadly neutralizing HIV-specific antibody, is safe, is well-tolerated, generated high plasma concentrations and modestly delayed the return of HIV viral rebound in HIV-1 infected individuals after they stopped receiving antiretroviral therapy, according to a study published in the New England Journal of Medicine by researchers at the University of Alabama at Birmingham, the National Institutes of Health and the University of Pennsylvania Penn Center for AIDS Research.

10 Nov 2016

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

The National Center for Advancing Translational Sciences recently awarded $596,533.00 to Collaborations Pharmaceuticals, Inc. to initiate a partnership with Texas Biomedical Research Institute aimed at repurposing an antimalarial for use against the Ebola virus.

10 Nov 2016

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

A study led by researchers at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research, Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV.

9 Nov 2016

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

A Ludwig Cancer Research study shows that an experimental drug currently in clinical trials can reverse the effects of troublesome cells that prevent the body's immune system from attacking tumors.

9 Nov 2016

Investigational treatment combination improves virologic control in SIV-infected monkeys

Researchers have found that an investigational treatment combination of a therapeutic vaccine and an immune-stimulator improves virologic control and delays viral rebound following the discontinuation of antiretroviral therapy (ART) in non-human primates infected with SIV, the simian form of HIV.

9 Nov 2016

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

A large national study has confirmed the value of high-intensity statin treatments for people with cardiovascular disease, according to researchers at the Stanford University School of Medicine.

9 Nov 2016

Certain anti-diabetic drugs can switch off molecule that plays key role in inflammatory diseases

A molecule thought to play a key role in some inflammatory diseases can be switched off by two widely used medicines, new research has shown.

9 Nov 2016

Scientists find new way to bypass bowel cancer's defence against treatment

BLOCKING a molecule could bypass bowel cancer's defence against the drug cetuximab, according to new research presented at the National Cancer Research Institute Cancer Conference in Liverpool.

9 Nov 2016

Research shows new role for plasmids in antibiotic resistance

A new study led by scientists at the University of Oxford has found that small DNA molecules known as plasmids are one of the key culprits in spreading the major global health threat of antibiotic resistance.

8 Nov 2016

BD introduces first insulin syringe for people with diabetes taking Humulin R U-500

BD, a leading global medical technology company announced today the launch of the BD U-500 Insulin Syringe, the first insulin syringe developed for people with diabetes taking Humulin R U-500 insulin, which is manufactured by Eli Lilly & Company.

8 Nov 2016

President and CEO of MMIS to discuss case study at CBI 3rd Global Compliance Congress for Life Sciences

MMIS President and CEO Michaeline Daboul will be speaking at the CBI 3rd Annual Global Compliance Congress for Life Sciences, in London on November 16-17.

8 Nov 2016

Advances in RNA research could pave new way for development of anti-cancer drugs

An international research team led by the University of Leicester has made a breakthrough advance that could pave a new route for the development of anti-cancer drugs.

8 Nov 2016

Scientists turn iron-scavenging power against common UTI-causing bacteria

For most invading bacteria, the bladder is not a friendly place. But for those that have figured out how to scavenge iron from their hosts, it's a fine place to grow and reproduce.

7 Nov 2016

Biologic drugs may help prevent progressive bone loss in patients with RA

A new review by the International Osteoporosis Foundation Chronic Inflammation and Bone Structure Working Group concludes that early and aggressive treatment of Rheumatoid Arthritis (RA) with biologic drugs, specifically biological disease-modifying anti-rheumatic drugs (DMARDs), may be most effective in halting progressive bone loss in patients with RA.

7 Nov 2016

Pharmaceutical News

C-SOPS, Thermo Fisher Scientific to accelerate research on continuous manufacturing techniques for drug discovery

Arthritis drug increases effectiveness of antidepressants in bipolar patients

International consortium awarded $36.9 million grant to accelerate introduction of new typhoid vaccines

New research shows how synthetic DNA vaccine approach protects against Zika virus infection

Researchers lay foundation for improved TB treatment by targeting new enzyme

Allergan launches first and only oral contraceptive in softgel capsule for prevention of pregnancy

Broadly neutralizing antibody delays return of viral rebound in HIV-1 infected individuals

NCATS funds collaboration initiative aimed at repurposing antimalarial to combat Ebola virus

Experimental vaccine/immune stimulant combination may lead to viral remission in HIV patients

Ludwig study shows how experimental drug can reverse effects of suppressive immune cells

Investigational treatment combination improves virologic control in SIV-infected monkeys

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

Certain anti-diabetic drugs can switch off molecule that plays key role in inflammatory diseases

Scientists find new way to bypass bowel cancer's defence against treatment

Research shows new role for plasmids in antibiotic resistance

BD introduces first insulin syringe for people with diabetes taking Humulin R U-500

President and CEO of MMIS to discuss case study at CBI 3rd Global Compliance Congress for Life Sciences

Advances in RNA research could pave new way for development of anti-cancer drugs

Scientists turn iron-scavenging power against common UTI-causing bacteria

Biologic drugs may help prevent progressive bone loss in patients with RA

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News